“Another measure looked at fibrosis, which is me
Post# of 148189
(Total Views: 575)
Posted On: 12/20/2022 11:23:27 PM
“Another measure looked at fibrosis, which is measured in five stages. There, 26% of patients showed an improvement of at least one stage in fibrosis while their symptoms didn't progress.”
26% of 950 is 247 patients that experienced non progression of Fibrosis. Or I guess an improvement. It’s a little beyond me to compare that to Leronlimab. Without side by side top line comparisons.
Read More: https://investorshangout.com/post/view?id=651...z7o4iX7xw6
26% of 950 is 247 patients that experienced non progression of Fibrosis. Or I guess an improvement. It’s a little beyond me to compare that to Leronlimab. Without side by side top line comparisons.
Read More: https://investorshangout.com/post/view?id=651...z7o4iX7xw6
(0)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼